# Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site) – FDA Inspection, Aug 29, 2023

Source: https://www.keypedia.com/records/fda_inspections/jiangsu-hengrui-pharmaceuticals-co-ltd-dongjin-road-site/98209768-4c21-453c-a664-bfc91b0894f5
Source feed: FDA_Inspections

> FDA inspection 1222323 of Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site), August 29, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222323
- Company Name: Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)
- Inspection Date: 2023-08-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1330154 - 2026-07-03](https://www.keypedia.com/records/fda_inspections/jiangsu-hengrui-pharmaceuticals-co-ltd-dongjin-road-site/5a9b37d9-43c9-4b12-8df8-bcc65712850f)
- FDA Inspection 943139 - 2015-08-24

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/cynthia-jim/e0f1c8a7-d787-442a-911c-61e37cd806a6)

Company: https://www.keypedia.com/companies/jiangsu-hengrui-pharmaceuticals-co-ltd-dongjin-road-site/91cc5f1a-20dc-4832-bbdf-0af7d9268c3b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c